Made possible with support from Genentech BioOncology
During this program, two leading breast cancer experts, one a medical oncologist and one a radiation oncologist, as well as a breast cancer survivor, will help you understand the treatment options for metastatic breast cancer and what factors influence the selection of treatment. There is no single treatment for metastatic breast cancer. Treatment choice depends on a variety of factors, such as tumor site and characteristics, genetic variables, prior treatment and comorbidities (the presence of one or more disorders (or diseases) in addition to a primary disease or disorder). As an empowered patient, it’s important you take an active role in your own health care decision-making, including requesting tests to identify the genetic characteristics of your breast cancer and understanding the results and implications of these laboratory results. Learn tips on how to deal with some of the physical and emotional side effects from treatment, as well as how a diagnosis of metastatic breast cancer for one woman inspired her to help women who face a similar diagnosis on their journey.
|
Hope Rugo, M.D.
Director of Breast Oncology and Clinical Trial Education, UCSF Helen Diller Family Comprehensive Cancer Center, UCSF Medical Center
Dr. Hope Rugo is Director of Breast Oncology and Clinical Trial Education at the UCSF Helen Diller Family Comprehensive Cancer Center of UCSF Medical Center. Dr. Rugo graduated from the University of Pennsylvania School of Medicine. She went on to complete a residency in internal medicine and primary care followed by a fellowship in hematology and oncology at UCSF. In...
more >
|
|
|
|
Robert Prosnitz, M.D., MPH
Assistant Professor, Department of Radiation Oncology, University of Pennsylvania Health System
Dr. Robert Prosnitz is an Assistant Professor in the Department of Radiation Oncology at Penn Medicine. He completed his medical degree at Duke University School of Medicine followed by an internship at Beth Israel Hospital in Boston and a residency at Harvard University. Dr. Prosnitz also holds a Masters in Public Health from Duke University School of Medicine. He is...
more >
|
|
|
|
Dikla Benzeevi,
Breast Cancer Patient Advocate
Dikla, 40 years old, from Los Angeles CA, was diagnosed with a tumor in her breast at age 32. About six months after she had finished her first year of treatment, an oncologist discovered a tumor in her spine and what would later be diagnosed as metastatic breast cancer (stage IV). Dikla underwent a number of different treatment modalities, including...
more >
|
|
|

